{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:43:14Z","timestamp":1788370994933,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cancer targeted therapy is essential to minimize damage to normal cells and improve treatment outcomes. The elevated activity of Cystathionine beta-synthase (CBS), an enzyme responsible for producing endogenous hydrogen sulfide (H<jats:sub>2<\/jats:sub>S), plays a significant role in promoting tumor growth, invasiveness, and metastatic potential. Consequently, the selective inhibition of CBS could represent a promising therapeutic strategy for cancer. Currently, there is much interest in combining paclitaxel with other drugs for cancer treatment. This study aimed to investigate the efficacy of combining benserazide, a CBS inhibitor, with paclitaxel in treating tumors. Firstly, we demonstrated CBS is indeed involved in the progression of multiple cancers. Then it was observed that the total binding free energy between the protein and the small molecule is \u221298.241\u00a0kJ\/mol. The release of H<jats:sub>2<\/jats:sub>S in the group treated with 100\u00a0\u03bcM benserazide was reduced by approximately 90% compared to the negative control, and the thermal denaturation curve of the complex protein shifted to the right, suggesting that benserazide binds to and blocks the CBS protein. Next, it was found that compared to paclitaxel monotherapy, the combination of benserazide with paclitaxel demonstrated stronger antitumor activity in KYSE450, A549, and HCT8 cells, accompanied by reduced cell viability, cell migration and invasion, as well as diminished angiogenic and lymphangiogenic capabilities. <jats:italic>In vivo<\/jats:italic> studies showed that the combined administration of benserazide and paclitaxel significantly reduced the volume and weight of axillary lymph nodes in comparison to the control group and single administration group. Further mechanistic studies revealed that the combination of benserazide and paclitaxel significantly suppressed the S-sulfhydration of SIRT1 protein, thereby inhibiting the expression of SIRT1 protein and activating SIRT1 downstream Notch1\/Hes1 signaling pathway in KYSE450, A549, and HCT8 cells. Meanwhile, we observed that benserazide combined with paclitaxel induced a more significant downregulation of HIF-1\u03b1, VEGF-A, VEGF-C, and VEGF-D proteins expression levels in KYSE450, A549, and HCT8 cells compared to paclitaxel alone. These findings indicated that benserazide enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and down-regulating HIF-1\u03b1\/VEGF signaling pathway. This study suggests that benserazide may have potential as a chemosensitizer in cancer treatment.<\/jats:p>","DOI":"10.3389\/fphar.2024.1404532","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T04:36:49Z","timestamp":1715920609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-\u03b1\/VEGF pathway"],"prefix":"10.3389","volume":"15","author":[{"given":"Wei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/biom9120789","article-title":"Paclitaxel's mechanistic and clinical effects on breast cancer","volume":"9","author":"Abu","year":"2019","journal-title":"Biomolecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18632\/oncotarget.28355","article-title":"Everolimus downregulates STAT3\/HIF-1\u03b1\/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)","volume":"14","author":"Alam","year":"2023","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3390\/ijms20133153","article-title":"The role of SIRT1 on DNA damage response and epigenetic alterations in cancer","volume":"20","author":"Alves-Fernandes","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"120263","DOI":"10.1016\/j.jns.2022.120263","article-title":"The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: a retrospective cohort study","volume":"437","author":"Baba","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3978\/j.issn.2072-1439.2015.04.01","article-title":"Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin","volume":"7","author":"Cao","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1038\/s41598-020-71469-x","article-title":"Cystathionine \u03b2-synthase is involved in cysteine biosynthesis and H2S generation in Toxoplasma gondii","volume":"10","author":"Conter","year":"2020","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.phrs.2016.08.016","article-title":"Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine \u03b2-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer","volume":"113","author":"Druzhyna","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/1759-7714.13925","article-title":"Quercetin induces pro-apoptotic autophagy via SIRT1\/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro","volume":"12","author":"Guo","year":"2021","journal-title":"Thorac. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41419-019-1525-1","article-title":"Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases","volume":"10","author":"Han","year":"2019","journal-title":"Cell. Death Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"114392","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.prp.2018.07.022","article-title":"The clinicopathological significance of SIRT1 expression in colon cancer: an immunohistochemical study and meta-analysis","volume":"214","author":"Hong","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1901858","DOI":"10.1002\/adhm.201901858","article-title":"Co-delivery of paclitaxel and interleukin-12 regulating tumor microenvironment for cancer immunochemotherapy","volume":"9","author":"Hu","year":"2020","journal-title":"Adv. Healthc. Mater"},{"key":"B13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B14","first-page":"1194","article-title":"MTA1-specific shRNA inhibits the growth and metastasis of mouse xenograft of laryngeal squamous cell carcinoma","volume":"31","author":"Liu","year":"2015","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13019-018-0718-5","article-title":"SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma","volume":"13","author":"Ma","year":"2018","journal-title":"J. Cardiothorac. Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.21873\/cdp.10086","article-title":"SIRT1 expression is a promising prognostic biomarker in esophageal squamous cell carcinoma: a systematic review and meta-analysis","volume":"2","author":"Otsuka","year":"2022","journal-title":"Cancer Diagn Progn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13059-021-02375-2","article-title":"Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation","volume":"22","author":"Padmanabhan","year":"2021","journal-title":"Genome Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox12030647","article-title":"Role of cystathionine \u03b2-synthase and 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation, migration, and bioenergetics of murine breast cancer cells","volume":"12","author":"Santos","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"114458","DOI":"10.1016\/j.biopha.2023.114458","article-title":"Autophagy in cancer resistance to paclitaxel: development of combination strategies","volume":"161","author":"\u0160kubn\u00edk","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.drup.2022.100881","article-title":"Paclitaxel resistance related to nuclear envelope structural sturdiness","volume":"65","author":"Smith","year":"2022","journal-title":"Drug Resist Updat"},{"key":"B21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12951-023-02020-z","article-title":"HIF-1\u03b1 increases the osteogenic capacity of ADSCs by coupling angiogenesis and osteogenesis via the HIF-1\u03b1\/VEGF\/AKT\/mTOR signaling pathway","volume":"21","author":"Song","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/cancers16010125","article-title":"SIRT1 promotes cisplatin resistance in bladder cancer via Beclin1 deacetylation-mediated autophagy","volume":"16","author":"Sun","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bcp.2017.10.007","article-title":"Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells","volume":"149","author":"Untereiner","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/jcmm.17107","article-title":"The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin","volume":"26","author":"Wang","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2174649","DOI":"10.1080\/13510002.2023.2174649","article-title":"Cystathionine \u03b3-lyase S-sulfhydrates SIRT1 to attenuate myocardial death in isoprenaline-induced heart failure","volume":"28","author":"Wu","year":"2023","journal-title":"Redox Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S2468-1253(21)00313-7","article-title":"Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial","volume":"6","author":"Xu","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12883-023-03411-3","article-title":"Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jare.2020.07.006","article-title":"Targeting hydrogen sulphide signaling in breast cancer","volume":"27","author":"Youness","year":"2020","journal-title":"J. Adv. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamaoncol.2020.2965","article-title":"Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1404532\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T04:36:55Z","timestamp":1715920615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1404532\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":30,"alternative-id":["10.3389\/fphar.2024.1404532"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1404532","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]},"article-number":"1404532"}}